影像组学模型覆盖瘤周变化提高临床I期实性肺腺癌预后准确性
本研究纳入两个中心334例术后临床I期实性肺腺癌患者,基于CT构建四种不同感兴趣体积的影像组学模型预测无病生存期。基于跨越肿瘤边界的6 mm感兴趣体积模型在内部和外部测试集中AUC均优于其他三种模型。
要点
- 跨越肿瘤边界6 mm的影像组学模型预测预后准确性优于仅含肿瘤或仅含瘤周的模型。
- 瘤周3 mm内外的影像组学特征对临床I期实性肺腺癌预后预测有附加价值。
- 该模型在外部验证集中表现稳定,支持多中心推广潜力。
核心结论
- 基于跨越肿瘤边界6 mm感兴趣体积的影像组学模型对临床I期实性肺腺癌的预后预测准确性高于基于肿瘤整体或仅瘤周3 mm、6 mm的模型。
研究设计与样本
- 回顾性研究,纳入来自两个中心的334例术后临床I期实性肺腺癌患者(中心1共204例,中心2共130例)。
- 构建三个数据库:数据集A(中心1训练集)、数据集B(中心1内部测试集)、数据集C(中心2外部验证集)。
- 基于CT影像构建四种感兴趣体积的影像组学模型:GTV、瘤周外3 mm(PTV0~+3)、跨越肿瘤边界6 mm(PTV-3~+3)、瘤周外6 mm(PTV0~+6)。
- 以无病生存期为结局,采用受试者工作特征曲线下面积比较模型准确性。
诊断标准与关键数值
- PTV-3~+3模型在数据集B和C的AUC分别为0.81(95%CI 0.75~0.94)和0.81(95%CI 0.63~0.90),优于GTV模型(0.73 [0.58~0.81]、0.73 [0.58~0.83])、PTV0~+3模型(0.76 [0.52~0.87]、0.75 [0.60~0.83])和PTV0~+6模型(0.72 [0.60~0.81]、0.69 [0.59~0.81]),所有p<0.05。
临床应用与阅片要点
- 对于临床I期实性肺腺癌,影像组学分析时应包含跨越肿瘤边界6 mm的瘤周区域以提升预后预测准确性。
- 仅基于肿瘤本身或仅瘤周的感兴趣体积可能低估预后风险,建议在报告中考虑瘤周浸润的影像组学特征。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess methods to improve the accuracy of prognosis for clinical stage I solid lung adenocarcinoma using radiomics based on different volumes of interests (VOIs).
METHODS: This retrospective study included patients with postoperative clinical stage I solid lung adenocarcinoma from two hospitals, center 1 and center 2. Three databases were generated: dataset A (training set from center 1), dataset B (internal test set from center 1), and dataset C (external validation test from center 2). Disease-free survival (DFS) data were collected. CT radiomics models were constructed based on four VOIs: gross tumor volume (GTV), 3 mm external to the tumor border (peritumoral volume [PTV]0~+3), 6 mm crossing tumor border (PTV-3~+3), and 6 mm external to the tumor border (PTV0~+6). The area under the receiver operating characteristic curve (AUC) was used to compare the model accuracies.
RESULTS: A total of 334 patients were included (204 and 130 from centers 1 and 2). The model using PTV-3~+3 (AUC 0.81 [95% confidence interval {CI}: 0.75, 0.94], 0.81 [0.63, 0.90] for datasets B and C) outperformed the other three models, GTV (0.73 [0.58, 0.81], 0.73 [0.58, 0.83]), PTV0~+3 (0.76 [0.52, 0.87], 0.75 [0.60, 0.83]), and PTV0~+6 (0.72 [0.60, 0.81], 0.69 [0.59, 0.81]), in datasets B and C, all p < 0.05.
CONCLUSIONS: A radiomics model based on a VOI of 6 mm crossing tumor border more accurately predicts prognosis of clinical stage I solid lung adenocarcinoma than that based on VOIs including overall tumor or external rims of 3 mm and 6 mm.
KEY POINTS: • Radiomics is a useful approach to improve the accuracy of prognosis for stage I solid adenocarcinoma. • The radiomics model based on VOIs that includes 3 mm within and external to the tumor border (peritumoral volume [PTV]-3~+3) outperformed models that included either only the tumor itself or those that only included the peritumoral volume.
引用
- Liu K, Li K, Wu T, et al. Improving the accuracy of prognosis for clinical stage I solid lung adenocarcinoma by radiomics models covering tumor per se and peritumoral changes on CT. Eur Radiol. 2021. PMID: 34453574. doi:10.1007/s00330-021-08194-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。